Advanced Inhalation Therapies Ltd. (AIT) has announced the completion of a successful financing round, in which it has raised $1.25 million. AIT is developing nitric oxide based treatments for infectious lung diseases. The company says the funds will be used for two clinical trials.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

A Promising Treatment For Trauma-Induced Fibromyalgia
March 23, 2023

Generative AI Startup Helps Developers Test Code Logic
March 23, 2023

Cream Cheese And Cheddar Cheese – Made From Chickpeas
March 22, 2023

$8M For Startup That Digitizes The Construction Supply Chain
March 22, 2023
Facebook comments